Corbus Pharmaceuticals Holdings (CRBP) Cash from Investing Activities Growth (5y) (2019 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash from Investing Activities Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 222.30% |
| Jun 30, 2025 | 305.70% |
| Mar 31, 2025 | 110.26% |
| Dec 31, 2024 | 54.35% |
| Sep 30, 2024 | -66.68% |
| Jun 30, 2024 | -145.78% |
| Mar 31, 2024 | -321.76% |
| Dec 31, 2023 | 112.76% |
| Sep 30, 2023 | 153.65% |
| Jun 30, 2023 | 71.98% |
| Mar 31, 2023 | 44.82% |
| Dec 31, 2022 | 86.07% |
| Sep 30, 2022 | -165.30% |
| Jun 30, 2022 | -239.12% |
| Mar 31, 2022 | 303.72% |
| Dec 31, 2021 | -101.35% |
| Sep 30, 2021 | 43.41% |
| Jun 30, 2021 | -154.86% |
| Mar 31, 2021 | -287.98% |
| Dec 31, 2020 | 20.68% |